NCT05288348View on ClinicalTrials.gov

DSUVIA Early Evaluation of Pain Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

August 5, 2022

Primary Completion Date

January 21, 2024

Study Completion Date

January 21, 2024

Conditions
Traumatic Injury
Interventions
DRUG

Sufentanil 30 MCG Sublingual Tablet

30 microgram sublingual tablet administered using sublingual applicator

DRUG

standard care pain treatment

standard care pain treatment given in Emergency Department

Trial Locations (1)

15213

University of Pittsburgh, Pittsburgh

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Frank Guyette

OTHER